Paclitaxel

Janessa Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Paclitaxel is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Second-line treatment of AIDS-related Kaposi’s sarcoma
  • Adjuvant therapy for node-positive breast cancer
  • Second-line treatment of metastatic breast cancer
  • First-line treatment of non-small cell lung cancer (in combination with cisplatin or carboplatin)
  • Second-line treatment of metastatic ovarian cancer

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Second-line treatment of AIDS-related Kaposi’s sarcoma
  • Adjuvant therapy for node-positive breast cancer
  • Second-line treatment of metastatic breast cancer
  • First-line treatment of non-small cell lung cancer (in combination with cisplatin or carboplatin)
  • Second-line treatment of metastatic ovarian cancer

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 4, 2016